Avonex Boasts Superior Adherence Rates
This article was originally published in The Pink Sheet Daily
Executive Summary
Patients taking Biogen’s MS therapy stuck to their regimen better than those taking Rebif, Betaferon or Copaxone in a global study, Biogen reports.